👏 Congratulations to Pedro Ochoa-Allemant of the University of Pennsylvania for receiving the 2025 #AASLDFoundation Anna S. Lok Advanced/Transplant #Hepatology Fellow Award!

New research out in @jamainternalmed.com compares risk of adverse liver outcomes, cardiovascular events & mortality across steatotic liver disease subtypes ft. @ochoaallemantmd.bsky.social, David Kaplan, @SerperM (@PennGIHep) & @rhubbbstat.bsky.social (@BrownBiostats) jamanetwork.com/journals/jam...

🚨 Our last paper is out in @jamainternalmed.com We compared the incidence of adverse liver outcomes, cardiovascular events, and mortality between MASLD, MetALD & ALD and found substantial differences! 🙏 @serperm.bsky.social @rhubbbstat.bsky.social & #DavidKaplan for their mentorship and support!

🚨Check out our new study in @jhepatology.bsky.social ❗️ Using natural language processing to identify >350,000 patients with #steatosis, we demonstrated that cause-specific mortality differs between #MASLD #MetALD and #ALD www.journal-of-hepatology.eu/article/S016...

This is an interesting letter to the editor that highlights the pitfalls of poorly validated ICD-10 codes and confirms my growing concerns with the increasingly popular but alarmingly weak TriNetX database and platform @zachsmithgi.bsky.social #gisky #liversky